C4 THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.74 USD | +4.82% |
|
+9.24% | +19.29% |
Chart calendar C4 Therapeutics, Inc.
e6e73271829d099060.Mc3WHXO2Aok-Jq7vGJ4uP5eqzgRhuDxvY9odSq3m_P4.bvuSKTqAePBWdujbbM8WDubymlc76VENMalMDvSSrKlanIBFFd9OuUp_ng~497348055cf4073fa026828499d1e196
Upcoming events on C4 Therapeutics, Inc.
Past events on C4 Therapeutics, Inc.
| 01/05/2024 | Q1 2024 Earnings Release (Projected) |
| 16/04/2024 15:30 | Stifel Virtual Targeted Oncology Days Conference |
| 09/04/2024 21:30 | American Association for Cancer Research Meeting - Abstract No : 6064 |
| 08/04/2024 17:00 | American Association for Cancer Research Meeting - Abstract No : 1658 |
| 04/04/2024 | American Association for Cancer Research Meeting |
| 11/03/2024 15:20 | Leerink Partners Global Biopharma Conference |
| 04/03/2024 19:50 | TD Cowen Health Care Conference |
| 22/02/2024 12:00 | Q4 2023 Earnings Release |
| 11/01/2024 17:00 | JPMorgan Healthcare Conference |
| 12/12/2023 21:30 | CFT7455 Phase 1 Study Results Call |
| 14/11/2023 20:00 | Stifel Healthcare Conference |
| 07/11/2023 | BMO BioPharma Spotlight Series: Oncology |
| 07/11/2023 | UBS Biopharma Conference |
| 02/11/2023 13:00 | Connective Tissue Oncology Society Meeting |
| 01/11/2023 11:00 | Q3 2023 Earnings Release |
| 08/08/2023 12:00 | Q2 2023 Earnings Release |
| 14/06/2023 | Annual General Meeting |
| 06/06/2023 | Jefferies Global Healthcare Conference |
| 03/06/2023 14:00 | American Society of Clinical Oncology Conference |
| 04/05/2023 12:00 | Q1 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 21,4 | 33,2 32,9 0.85% | 45,8 33,1 38.4% | 31,1 39,8 -21.86% | 20,8 21,5 -3.63% | 26,3 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -55,4 -59,5 6.94% | -59,1 -88,3 33.07% | -97,8 -88,9 -10.12% | -110 -111 1.39% | -89,1 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -60,4 -62,2 2.83% | -82,1 -94,0 12.63% | -130 -112 -15.31% | -139 -135 -2.7% | -134 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -67,0 -63,6 -5.28% | -83,9 -98,5 14.79% | -128 -127 -0.91% | -131 -138 4.58% | -132 |
|
Net income Million USD | Released Forecast Spread | 0,00 | -66,3 -72,0 7.91% | -83,9 -98,2 14.59% | -128 -125 -2.38% | -132 -138 3.69% | -139 |
|
EPS USD | Released Forecast Spread | -3,67 | -1,54 -2,54 39.39% | -1,82 -2,09 13.05% | -2,62 -2,49 -5.11% | -2,67 -2,63 -1.61% | -1,93 |
| Announcement Date | 10/09/20 | 11/03/21 | 24/02/22 | 23/02/23 | 22/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 20,1 7,70 160.82% | 7,65 8,05 -4.91% | 13,8 8,51 62.61% | 6,75 9,26 -27.08% | 2,85 10,9 -73.92% | 3,76 5,46 -31.19% | 2,66 6,44 -58.63% | 11,1 5,46 102.8% | 3,26 3,21 1.49% | 9,28 | 3,88 | 6,42 | 3,70 |
|
EBITDA Million USD | Released Forecast Spread | -8,58 -22,8 62.33% | -31,1 -18,6 -66.61% | -26,9 -19,0 -41.97% | -32,1 -20,4 -57.07% | -30,9 -10,4 -195.58% | -35,7 -26,8 -33.23% | -30,7 -23,5 -30.77% | -27,4 -28,5 4.16% | -30,6 -33,9 9.52% | -18,3 | -23,3 | -20,7 | -23,7 |
|
EBIT Million USD | Released Forecast Spread | -15,3 -27,2 43.98% | -31,4 -27,7 -13.41% | -27,4 -30,7 10.92% | -32,5 -29,9 -8.79% | -38,3 -28,0 -36.55% | -36,2 -36,6 1.05% | -37,6 -35,3 -6.56% | -27,8 -36,4 23.53% | -37,4 -38,9 3.74% | -27,1 | -32,4 | -30,5 | -36,0 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -15,7 -30,2 48.15% | -31,6 -30,5 -3.63% | -27,4 -34,8 21.18% | -32,0 -32,8 2.64% | -37,2 -36,0 -3.24% | -34,8 -37,1 6.32% | -35,9 -36,2 0.72% | -26,0 -38,1 31.6% | -34,5 -39,1 11.87% | -24,5 | -31,4 | -29,1 | -35,4 |
|
Net income Million USD | Released Forecast Spread | -15,7 -28,0 44.07% | -31,6 -29,5 -7.31% | -27,4 -33,1 17.08% | -32,0 -33,3 3.95% | -37,2 -33,7 -10.43% | -34,8 -37,9 8.17% | -35,9 -36,8 2.36% | -27,0 -36,8 26.6% | -34,8 -38,9 10.55% | -27,1 | -33,0 | -31,8 | -36,6 |
|
EPS USD | Released Forecast Spread | -0,31 -0,57 45.89% | -0,65 -0,59 -10.29% | -0,56 -0,65 14.32% | -0,65 -0,67 3.69% | -0,76 -0,67 -14.02% | -0,71 -0,77 7.66% | -0,73 -0,75 2.54% | -0,55 -0,69 19.78% | -0,68 -0,70 2.77% | -0,41 | -0,49 | -0,47 | -0,49 |
| Announcement Date | 24/02/22 | 05/05/22 | 04/08/22 | 03/11/22 | 23/02/23 | 04/05/23 | 08/08/23 | 01/11/23 | 22/02/24 | - | - | - | - |
More events
Past sector events for C4 Therapeutics, Inc.
| 02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- CCCC Stock
- Calendar C4 Therapeutics, Inc.
